Copyright Reports & Markets. All rights reserved.

Global Montelukast Drug Sales Market Report 2021

Request for Sample of this report
Buy now

1 Montelukast Drug Market Overview

  • 1.1 Montelukast Drug Product Scope
  • 1.2 Montelukast Drug Segment by Type
    • 1.2.1 Global Montelukast Drug Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Tablets
    • 1.2.3 Oral Granules
  • 1.3 Montelukast Drug Segment by Application
    • 1.3.1 Global Montelukast Drug Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hospital
    • 1.3.3 Drug Store
    • 1.3.4 Others
  • 1.4 Montelukast Drug Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Montelukast Drug Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Montelukast Drug Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Montelukast Drug Price Trends (2016-2027)

2 Montelukast Drug Estimates and Forecasts by Region

  • 2.1 Global Montelukast Drug Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Montelukast Drug Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Montelukast Drug Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Montelukast Drug Revenue Market Share by Region (2016-2021)
  • 2.3 Global Montelukast Drug Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Montelukast Drug Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Montelukast Drug Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Montelukast Drug Estimates and Projections (2016-2027)
    • 2.4.2 Europe Montelukast Drug Estimates and Projections (2016-2027)
    • 2.4.3 China Montelukast Drug Estimates and Projections (2016-2027)
    • 2.4.4 Japan Montelukast Drug Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Montelukast Drug Estimates and Projections (2016-2027)
    • 2.4.6 India Montelukast Drug Estimates and Projections (2016-2027)

3 Global Montelukast Drug Competition Landscape by Players

  • 3.1 Global Top Montelukast Drug Players by Sales (2016-2021)
  • 3.2 Global Top Montelukast Drug Players by Revenue (2016-2021)
  • 3.3 Global Montelukast Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Montelukast Drug as of 2020)
  • 3.4 Global Montelukast Drug Average Price by Company (2016-2021)
  • 3.5 Manufacturers Montelukast Drug Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Montelukast Drug Market Size by Type

  • 4.1 Global Montelukast Drug Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Montelukast Drug Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Montelukast Drug Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Montelukast Drug Price by Type (2016-2021)
  • 4.2 Global Montelukast Drug Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Montelukast Drug Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Montelukast Drug Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Montelukast Drug Price Forecast by Type (2022-2027)

5 Global Montelukast Drug Market Size by Application

  • 5.1 Global Montelukast Drug Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Montelukast Drug Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Montelukast Drug Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Montelukast Drug Price by Application (2016-2021)
  • 5.2 Global Montelukast Drug Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Montelukast Drug Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Montelukast Drug Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Montelukast Drug Price Forecast by Application (2022-2027)

6 North America Montelukast Drug Market Facts & Figures

  • 6.1 North America Montelukast Drug Sales by Company
    • 6.1.1 North America Montelukast Drug Sales by Company (2016-2021)
    • 6.1.2 North America Montelukast Drug Revenue by Company (2016-2021)
  • 6.2 North America Montelukast Drug Sales Breakdown by Type
    • 6.2.1 North America Montelukast Drug Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Montelukast Drug Sales Breakdown by Type (2022-2027)
  • 6.3 North America Montelukast Drug Sales Breakdown by Application
    • 6.3.1 North America Montelukast Drug Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Montelukast Drug Sales Breakdown by Application (2022-2027)

7 Europe Montelukast Drug Market Facts & Figures

  • 7.1 Europe Montelukast Drug Sales by Company
    • 7.1.1 Europe Montelukast Drug Sales by Company (2016-2021)
    • 7.1.2 Europe Montelukast Drug Revenue by Company (2016-2021)
  • 7.2 Europe Montelukast Drug Sales Breakdown by Type
    • 7.2.1 Europe Montelukast Drug Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Montelukast Drug Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Montelukast Drug Sales Breakdown by Application
    • 7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)

8 China Montelukast Drug Market Facts & Figures

  • 8.1 China Montelukast Drug Sales by Company
    • 8.1.1 China Montelukast Drug Sales by Company (2016-2021)
    • 8.1.2 China Montelukast Drug Revenue by Company (2016-2021)
  • 8.2 China Montelukast Drug Sales Breakdown by Type
    • 8.2.1 China Montelukast Drug Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Montelukast Drug Sales Breakdown by Type (2022-2027)
  • 8.3 China Montelukast Drug Sales Breakdown by Application
    • 8.3.1 China 174 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 174 Sales Breakdown by Application (2022-2027)

9 Japan Montelukast Drug Market Facts & Figures

  • 9.1 Japan Montelukast Drug Sales by Company
    • 9.1.1 Japan Montelukast Drug Sales by Company (2016-2021)
    • 9.1.2 Japan Montelukast Drug Revenue by Company (2016-2021)
  • 9.2 Japan Montelukast Drug Sales Breakdown by Type
    • 9.2.1 Japan Montelukast Drug Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Montelukast Drug Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Montelukast Drug Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Montelukast Drug Market Facts & Figures

  • 10.1 Southeast Asia Montelukast Drug Sales by Company
    • 10.1.1 Southeast Asia Montelukast Drug Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Montelukast Drug Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Montelukast Drug Sales Breakdown by Type
    • 10.2.1 Southeast Asia Montelukast Drug Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Montelukast Drug Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Montelukast Drug Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Montelukast Drug Market Facts & Figures

  • 11.1 India Montelukast Drug Sales by Company
    • 11.1.1 India Montelukast Drug Sales by Company (2016-2021)
    • 11.1.2 India Montelukast Drug Revenue by Company (2016-2021)
  • 11.2 India Montelukast Drug Sales Breakdown by Type
    • 11.2.1 India Montelukast Drug Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Montelukast Drug Sales Breakdown by Type (2022-2027)
  • 11.3 India Montelukast Drug Sales Breakdown by Application
    • 11.3.1 India Montelukast Drug Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Montelukast Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Montelukast Drug Business

  • 12.1 Merck & Co.
    • 12.1.1 Merck & Co. Corporation Information
    • 12.1.2 Merck & Co. Business Overview
    • 12.1.3 Merck & Co. Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Merck & Co. Montelukast Drug Products Offered
    • 12.1.5 Merck & Co. Recent Development
  • 12.2 Teva
    • 12.2.1 Teva Corporation Information
    • 12.2.2 Teva Business Overview
    • 12.2.3 Teva Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Teva Montelukast Drug Products Offered
    • 12.2.5 Teva Recent Development
  • 12.3 Mylan
    • 12.3.1 Mylan Corporation Information
    • 12.3.2 Mylan Business Overview
    • 12.3.3 Mylan Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Mylan Montelukast Drug Products Offered
    • 12.3.5 Mylan Recent Development
  • 12.4 Glenmark Pharmaceuticals
    • 12.4.1 Glenmark Pharmaceuticals Corporation Information
    • 12.4.2 Glenmark Pharmaceuticals Business Overview
    • 12.4.3 Glenmark Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Glenmark Pharmaceuticals Montelukast Drug Products Offered
    • 12.4.5 Glenmark Pharmaceuticals Recent Development
  • 12.5 Hikma Group
    • 12.5.1 Hikma Group Corporation Information
    • 12.5.2 Hikma Group Business Overview
    • 12.5.3 Hikma Group Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Hikma Group Montelukast Drug Products Offered
    • 12.5.5 Hikma Group Recent Development
  • 12.6 Sandoz
    • 12.6.1 Sandoz Corporation Information
    • 12.6.2 Sandoz Business Overview
    • 12.6.3 Sandoz Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Sandoz Montelukast Drug Products Offered
    • 12.6.5 Sandoz Recent Development
  • 12.7 Torrent Pharmaceuticals
    • 12.7.1 Torrent Pharmaceuticals Corporation Information
    • 12.7.2 Torrent Pharmaceuticals Business Overview
    • 12.7.3 Torrent Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Torrent Pharmaceuticals Montelukast Drug Products Offered
    • 12.7.5 Torrent Pharmaceuticals Recent Development
  • 12.8 Lannett Company
    • 12.8.1 Lannett Company Corporation Information
    • 12.8.2 Lannett Company Business Overview
    • 12.8.3 Lannett Company Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Lannett Company Montelukast Drug Products Offered
    • 12.8.5 Lannett Company Recent Development
  • 12.9 Apotex
    • 12.9.1 Apotex Corporation Information
    • 12.9.2 Apotex Business Overview
    • 12.9.3 Apotex Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Apotex Montelukast Drug Products Offered
    • 12.9.5 Apotex Recent Development
  • 12.10 Dr. Reddys Laboratories
    • 12.10.1 Dr. Reddys Laboratories Corporation Information
    • 12.10.2 Dr. Reddys Laboratories Business Overview
    • 12.10.3 Dr. Reddys Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Dr. Reddys Laboratories Montelukast Drug Products Offered
    • 12.10.5 Dr. Reddys Laboratories Recent Development
  • 12.11 Aurobindo Pharma
    • 12.11.1 Aurobindo Pharma Corporation Information
    • 12.11.2 Aurobindo Pharma Business Overview
    • 12.11.3 Aurobindo Pharma Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Aurobindo Pharma Montelukast Drug Products Offered
    • 12.11.5 Aurobindo Pharma Recent Development
  • 12.12 Accord Healthcare
    • 12.12.1 Accord Healthcare Corporation Information
    • 12.12.2 Accord Healthcare Business Overview
    • 12.12.3 Accord Healthcare Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Accord Healthcare Montelukast Drug Products Offered
    • 12.12.5 Accord Healthcare Recent Development
  • 12.13 Hetero
    • 12.13.1 Hetero Corporation Information
    • 12.13.2 Hetero Business Overview
    • 12.13.3 Hetero Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Hetero Montelukast Drug Products Offered
    • 12.13.5 Hetero Recent Development
  • 12.14 Unimark
    • 12.14.1 Unimark Corporation Information
    • 12.14.2 Unimark Business Overview
    • 12.14.3 Unimark Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Unimark Montelukast Drug Products Offered
    • 12.14.5 Unimark Recent Development
  • 12.15 Ajanta Pharma
    • 12.15.1 Ajanta Pharma Corporation Information
    • 12.15.2 Ajanta Pharma Business Overview
    • 12.15.3 Ajanta Pharma Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Ajanta Pharma Montelukast Drug Products Offered
    • 12.15.5 Ajanta Pharma Recent Development
  • 12.16 MACLEODS
    • 12.16.1 MACLEODS Corporation Information
    • 12.16.2 MACLEODS Business Overview
    • 12.16.3 MACLEODS Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 MACLEODS Montelukast Drug Products Offered
    • 12.16.5 MACLEODS Recent Development
  • 12.17 Jubilant Pharma
    • 12.17.1 Jubilant Pharma Corporation Information
    • 12.17.2 Jubilant Pharma Business Overview
    • 12.17.3 Jubilant Pharma Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.17.4 Jubilant Pharma Montelukast Drug Products Offered
    • 12.17.5 Jubilant Pharma Recent Development
  • 12.18 Unichem Laboratories
    • 12.18.1 Unichem Laboratories Corporation Information
    • 12.18.2 Unichem Laboratories Business Overview
    • 12.18.3 Unichem Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.18.4 Unichem Laboratories Montelukast Drug Products Offered
    • 12.18.5 Unichem Laboratories Recent Development
  • 12.19 Amneal Pharmaceuticals
    • 12.19.1 Amneal Pharmaceuticals Corporation Information
    • 12.19.2 Amneal Pharmaceuticals Business Overview
    • 12.19.3 Amneal Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.19.4 Amneal Pharmaceuticals Montelukast Drug Products Offered
    • 12.19.5 Amneal Pharmaceuticals Recent Development
  • 12.20 Shanghai Anbison Lab
    • 12.20.1 Shanghai Anbison Lab Corporation Information
    • 12.20.2 Shanghai Anbison Lab Business Overview
    • 12.20.3 Shanghai Anbison Lab Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.20.4 Shanghai Anbison Lab Montelukast Drug Products Offered
    • 12.20.5 Shanghai Anbison Lab Recent Development
  • 12.21 Perrigo
    • 12.21.1 Perrigo Corporation Information
    • 12.21.2 Perrigo Business Overview
    • 12.21.3 Perrigo Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.21.4 Perrigo Montelukast Drug Products Offered
    • 12.21.5 Perrigo Recent Development
  • 12.22 Cipla
    • 12.22.1 Cipla Corporation Information
    • 12.22.2 Cipla Business Overview
    • 12.22.3 Cipla Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.22.4 Cipla Montelukast Drug Products Offered
    • 12.22.5 Cipla Recent Development
  • 12.23 CSPC Ouyi Pharmaceutical
    • 12.23.1 CSPC Ouyi Pharmaceutical Corporation Information
    • 12.23.2 CSPC Ouyi Pharmaceutical Business Overview
    • 12.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Revenue and Gross Margin (2016-2021)
    • 12.23.4 CSPC Ouyi Pharmaceutical Montelukast Drug Products Offered
    • 12.23.5 CSPC Ouyi Pharmaceutical Recent Development

13 Montelukast Drug Manufacturing Cost Analysis

  • 13.1 Montelukast Drug Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Montelukast Drug
  • 13.4 Montelukast Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Montelukast Drug Distributors List
  • 14.3 Montelukast Drug Customers

15 Market Dynamics

  • 15.1 Montelukast Drug Market Trends
  • 15.2 Montelukast Drug Drivers
  • 15.3 Montelukast Drug Market Challenges
  • 15.4 Montelukast Drug Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Montelukast Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Montelukast Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Tablets
    Oral Granules

    Segment by Application
    Hospital
    Drug Store
    Others

    The Montelukast Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Montelukast Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Merck & Co.
    Teva
    Mylan
    Glenmark Pharmaceuticals
    Hikma Group
    Sandoz
    Torrent Pharmaceuticals
    Lannett Company
    Apotex
    Dr. Reddys Laboratories
    Aurobindo Pharma
    Accord Healthcare
    Hetero
    Unimark
    Ajanta Pharma
    MACLEODS
    Jubilant Pharma
    Unichem Laboratories
    Amneal Pharmaceuticals
    Shanghai Anbison Lab
    Perrigo
    Cipla
    CSPC Ouyi Pharmaceutical

    Buy now